International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
作者信息
Silverman S, Curtis J, Saag K, Flahive J, Adachi J, Anderson F, Chapurlat R, Cooper C, Diez-Perez A, Greenspan S, Hooven F, Le Croix A, March L, Netelenbos J C, Nieves J, Pfeilschifter J, Rossini M, Roux C, Siris E, Watts N, Compston J
机构信息
Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA,
出版信息
Osteoporos Int. 2015 Jan;26(1):419-20. doi: 10.1007/s00198-014-2883-2. Epub 2014 Sep 26.
Abstract
摘要
相似文献
1
International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.观察性GLOW研究中糖皮质激素暴露个体的骨骼健康国际管理。
Osteoporos Int. 2015 Jan;26(1):419-20. doi: 10.1007/s00198-014-2883-2. Epub 2014 Sep 26.
2
Glucocorticoid-induced osteoporosis: an update.糖皮质激素性骨质疏松症：最新进展
Trends Endocrinol Metab. 2006 May-Jun;17(4):144-9. doi: 10.1016/j.tem.2006.03.009.
3
Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population.糖皮质激素治疗是意大利绝经后人群骨质疏松症和骨折的重要危险因素。
Gynecol Endocrinol. 2013 Jul;29(7):678-82. doi: 10.3109/09513590.2013.788631. Epub 2013 May 2.
4
Prevention and management of steroid-induced osteoporosis.
Br J Hosp Med. 1994;52(2-3):86-9.
5
Teriparatide for glucocorticoid-induced osteoporosis.
J Rheumatol. 2012 Mar;39(3):461-2. doi: 10.3899/jrheum.111629.
6
Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review.糖皮质激素诱导的绝经后骨质疏松症动物模型：最新综述。
Biomed Pharmacother. 2016 Dec;84:438-446. doi: 10.1016/j.biopha.2016.09.045. Epub 2016 Sep 28.
7
Inhaled triamcinolone and chronic obstructive pulmonary disease.
N Engl J Med. 2001 May 17;344(20):1553-4; author reply 1554-6. doi: 10.1056/NEJM200105173442013.
8
[Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].[糖皮质激素性骨质疏松症。发生、预防及治疗]
Ugeskr Laeger. 2005 Feb 21;167(8):898-900.
9
Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.接受口服糖皮质激素治疗的绝经后加那利群岛妇女，椎体骨折患病率增加，通过定量计算机断层扫描和双能X线吸收法测量的骨密度值较低，甲状旁腺激素无显著变化。
Eur J Intern Med. 2008 Jan;19(1):51-6. doi: 10.1016/j.ejim.2007.08.005. Epub 2007 Nov 26.
10
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.唑来膦酸单次静脉输注与利塞膦酸钠每日口服治疗不同亚组糖皮质激素性骨质疏松症患者腰椎骨密度的事后分析。
Osteoporos Int. 2012 Mar;23(3):1083-90. doi: 10.1007/s00198-011-1800-1.
引用本文的文献
1
Mind the bone: a protocol for osteoporosis prophylaxis in patients with thyroid eye disease on intravenous methylprednisolone.关注骨骼：静脉注射甲泼尼龙治疗甲状腺眼病患者的骨质疏松预防方案
Eye (Lond). 2025 Aug 22. doi: 10.1038/s41433-025-03960-6.
2
Fufang Zhenshu Tiaozhi capsule enhances bone formation and safeguards against glucocorticoid-induced osteoporosis through innovative Mekk2-mediated β-catenin deubiquitination.复方贞术调脂胶囊通过创新的 Mekk2 介导的 β-catenin 去泛素化作用增强成骨作用并预防糖皮质激素诱导的骨质疏松症。
J Bone Miner Metab. 2024 Sep;42(5):516-528. doi: 10.1007/s00774-024-01516-4. Epub 2024 May 16.
3
The Dutch multidisciplinary guideline osteoporosis and fracture prevention, taking a local guideline to the international arena.荷兰多学科骨质疏松症和骨折预防指南，将地方指南推向国际舞台。
Arch Osteoporos. 2024 Apr 2;19(1):23. doi: 10.1007/s11657-024-01378-3.
4
Patients with osteoporosis: children of a lesser god.骨质疏松症患者：二等公民。
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002973.
5
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial.从双膦酸盐类药物转换为每周一次的特立帕肽后糖皮质激素性骨质疏松症的改善：一项随机开放标签试验
J Clin Med. 2022 Dec 30;12(1):292. doi: 10.3390/jcm12010292.
6
Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways.补肾活血汤通过调节NF-κB、ERK和JNK信号通路抑制RANKL刺激的破骨细胞生成和糖皮质激素诱导的骨质流失。
Front Pharmacol. 2022 Nov 18;13:1007839. doi: 10.3389/fphar.2022.1007839. eCollection 2022.
7
polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells.多糖能够抑制大鼠间充质干细胞来源的外泌体诱导的破骨细胞分化。
Pharm Biol. 2022 Dec;60(1):1303-1316. doi: 10.1080/13880209.2022.2093385.
8
MicroRNA-22 contributes to dexamethasone-induced osteoblast differentiation inhibition and dysfunction through targeting caveolin-3 expression in osteoblastic cells.微小RNA-22通过靶向成骨细胞中窖蛋白-3的表达，导致地塞米松诱导的成骨细胞分化抑制和功能障碍。
Exp Ther Med. 2021 Apr;21(4):336. doi: 10.3892/etm.2021.9767. Epub 2021 Feb 8.
9
Sodium hydrosulfide alleviates dexamethasone-induced cell senescence and dysfunction through targeting the miR-22/sirt1 pathway in osteoblastic MC3T3-E1 cells.硫化氢通过靶向成骨细胞MC3T3-E1细胞中的miR-22/sirt1通路减轻地塞米松诱导的细胞衰老和功能障碍。
Exp Ther Med. 2021 Mar;21(3):238. doi: 10.3892/etm.2021.9669. Epub 2021 Jan 21.
10
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.糖皮质激素性骨质疏松症的治疗现状与新进展。
Drugs. 2019 Jul;79(10):1065-1087. doi: 10.1007/s40265-019-01145-6.
Zotero 插件